News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
DAWES KAREN A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/22/2023 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 798 shares
@ $0
Granted 1,730 options to buy
@ $156.63, valued at
$271k
|
|
| 09/09/2022 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 775 shares
@ $227.17, valued at
$176.1k
|
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2021 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 462 shares
@ $259.75, valued at
$120k
Sold 236 shares
@ $261.1, valued at
$61.6k
Sold 1,038 shares
@ $262.28, valued at
$272.2k
Sold 1,119 shares
@ $263.23, valued at
$294.6k
Sold 336 shares
@ $264.21, valued at
$88.8k
Sold 488 shares
@ $265.27, valued at
$129.5k
Sold 486 shares
@ $266.72, valued at
$129.6k
Sold 349 shares
@ $267.75, valued at
$93.4k
Sold 255 shares
@ $269.94, valued at
$68.8k
Sold 14 shares
@ $271.28, valued at
$3.8k
Exercised 4,783 options to buy
@ $26.12, valued at
$124.9k
|
|
| 11/04/2021 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 64 shares
@ $299.02, valued at
$19.1k
Sold 251 shares
@ $301.2, valued at
$75.6k
Sold 446 shares
@ $301.97, valued at
$134.7k
Sold 532 shares
@ $303.48, valued at
$161.5k
Sold 124 shares
@ $304.23, valued at
$37.7k
Sold 700 shares
@ $305.91, valued at
$214.1k
Sold 283 shares
@ $306.49, valued at
$86.7k
|
|
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2021 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 288 shares
@ $200.01, valued at
$57.6k
Sold 806 shares
@ $201.37, valued at
$162.3k
Sold 2,877 shares
@ $202.29, valued at
$582k
Sold 614 shares
@ $203.11, valued at
$124.7k
|
|
| 07/15/2021 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 1,520 shares
@ $202.23, valued at
$307.4k
Exercised 2,929 options to buy
@ $41.19, valued at
$120.6k
|
|
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| DAWES KAREN A (Director) has filed a Form 4 on Vaccitech plc|
Txns:
| Bought 1,700 shares
@ $17, valued at
$28.9k
|
|
| 05/04/2021 |
4
| DAWES KAREN A (Director) has filed a Form 4 on Vaccitech plc|
Txns:
| Granted 34,328 options to buy
@ $17, valued at
$583.6k
|
|
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2020 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 10 shares
@ $135.91, valued at
$1.4k
Sold 43 shares
@ $136.98, valued at
$5.9k
Sold 282 shares
@ $139.4, valued at
$39.3k
Sold 182 shares
@ $140.29, valued at
$25.5k
|
|
| 05/19/2020 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 722 shares
@ $0
Sold 712 shares
@ $135.76, valued at
$96.7k
Sold 160 shares
@ $136.92, valued at
$21.9k
Sold 269 shares
@ $138.6, valued at
$37.3k
Sold 122 shares
@ $139.32, valued at
$17k
Sold 180 shares
@ $140.62, valued at
$25.3k
Sold 77 shares
@ $141.45, valued at
$10.9k
Sold 80 shares
@ $142.45, valued at
$11.4k
Granted 1,761 options to buy
@ $128.18, valued at
$225.7k
|
|
| 05/11/2020 |
4
| DAWES KAREN A (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Sold 15,834 shares
@ $0.7914, valued at
$12.5k
|
|
| 04/22/2020 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 3,202 shares
@ $104.98, valued at
$336.1k
Sold 8,998 shares
@ $104.42, valued at
$939.6k
Exercised 8,200 options to buy
@ $3.3, valued at
$27.1k
Exercised 11,800 options to buy
@ $3.3, valued at
$38.9k
|
|
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 1,295 shares
@ $77.35, valued at
$100.2k
Exercised 20,000 options to buy
@ $4.96, valued at
$99.2k
|
|
| 06/14/2019 |
4
| DAWES KAREN A (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Sold 12,500 shares
@ $3.1835, valued at
$39.8k
|
|
| 05/17/2019 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 1,292 shares
@ $0
Granted 2,953 options to buy
@ $67.71, valued at
$199.9k
|
|
| 05/09/2019 |
4
| DAWES KAREN A (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Granted 39,584 shares
@ $0
Exercised 31,250 restricted stock units
@ $0 |
|
| 12/04/2018 |
4
| DAWES KAREN A (Director) has filed a Form 4 on Assertio Therapeutics, Inc|
Txns:
| Sold 8,421 shares
@ $4.8361, valued at
$40.7k
Exercised 15,000 options
@ $1.49, valued at
$22.4k
|
|
| 05/17/2018 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 2,080 shares
@ $0
Granted 4,626 options to buy
@ $42.07, valued at
$194.6k
|
|
| 05/15/2018 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 20,000 shares
@ $41.7968, valued at
$835.9k
Exercised 20,000 options to buy
@ $5.08, valued at
$101.6k
|
|
| 05/10/2018 |
4
| DAWES KAREN A (Director) has filed a Form 4 on DEPOMED INC|
Txns:
| Granted 31,250 options to buy
@ $0 |
|
| 08/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/15/2016 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 06/28/2016 |
4
| DAWES KAREN A (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Paid exercise price by delivering 1,982 shares
@ $23.46, valued at
$46.5k
Exercised 15,000 options to buy
@ $3.1, valued at
$46.5k
|
|
|
|
|